Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01623388

Epigenetic Modifications of Diabetes Mellitus Type I

Epigenetic Modifications Induced by Glycemic Variability

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Scripps Translational Science Institute · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

This research is being done to find out if significant changes in blood glucose cause bad outcomes in patients with diabetes.

Conditions

Interventions

TypeNameDescription
PROCEDUREOral glucose tolerance test for Phase IOral glucose tolerance test for Diabetic patients in phase I

Timeline

Start date
2013-01-01
Primary completion
2014-01-01
First posted
2012-06-20
Last updated
2014-01-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01623388. Inclusion in this directory is not an endorsement.